SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+3.8%Nov 24 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (10465)10/30/1997 10:53:00 PM
From: squetch  Read Replies (1) of 32384
 
>>Are you suggesting LLY is running out of money?<<Yes(:>) they have to develop LGND's pipeline.

>>Do you know when the alliance with LLY began?<< 8.3.94 global strategic alliance that gives exclusive worldwide development, distribution, and mkting rights, except certain Asian countries, to SRGN's IL-2 fusion protein for the treatment of cancer. LLY has options to obtain the same rights for IL-2 or other products after looking at PII data for other indications. SRGN retains the dermatologic rights.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext